{"meta":{"query_hash":"93697f358479","filters":{"venue":"Drugs and Drug Candidates"},"cohort_total":6,"direct_labels_cover":0,"predictions_cover":6,"exported":6,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/93697f358479","api":"https://metacan.xera.ac/api/v1/cohort?venue=Drugs+and+Drug+Candidates"},"results":[{"id":"W4311111624","doi":"10.3390/ddc1010003","title":"Failed Repurposing of Lysosomotropic Drugs for COVID-19 Treatment or Prevention","year":2022,"lang":"en","type":"article","venue":"Drugs and Drug Candidates","topic":"COVID-19 Clinical Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research","keywords":"Phospholipidosis; Pharmacology; Repurposing; Drug repositioning; Hydroxychloroquine; Drug; Endocytosis; Microvesicles; Medicine; Coronavirus disease 2019 (COVID-19); Chemistry; Biology; Disease; Cell; Pathology; Biochemistry","score_opus":0.043191892989226696,"score_gpt":0.41197590143503965,"score_spread":0.36878400844581294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311111624","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97968924,0.0018460335,0.00035251962,0.014507054,0.00014417796,0.0026017465,0.00032466778,0.00009138136,0.00044315105],"genre_scores_gemma":[0.9829037,0.0009391569,0.0003982941,0.00070822047,0.000089055386,0.00058409246,0.000115912044,0.000020570322,0.014240972],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99838173,0.00012632244,0.00041852958,0.0004076399,0.00037198787,0.00029377016],"domain_scores_gemma":[0.99630046,0.0029029287,0.00016062096,0.00028448098,0.0000805768,0.00027095588],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006089956,0.00016466767,0.00050402345,0.00015078246,0.00042193622,0.00001994265,0.00008568429,0.000029816334,0.0003970154],"category_scores_gemma":[0.0028617731,0.00011624033,0.0001781049,0.00022093902,0.00014362251,0.000051882602,0.0001995095,0.00010989184,0.000001570885],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.040601227,0.007023851,0.22063763,0.013471195,0.004127489,0.00028140246,0.081673294,0.00077577896,0.009138329,0.004947938,0.03490618,0.5824157],"study_design_scores_gemma":[0.025208844,0.008156945,0.00457103,0.00023765092,0.0009911333,0.000010559129,0.0115921125,0.004245909,0.0067797974,0.004472023,0.93319255,0.0005414458],"about_ca_topic_score_codex":0.00070515677,"about_ca_topic_score_gemma":0.00006940488,"teacher_disagreement_score":0.89828634,"about_ca_system_score_codex":0.0004482154,"about_ca_system_score_gemma":0.00072380767,"threshold_uncertainty_score":0.4740143},"labels":[],"label_agreement":null},{"id":"W4353060534","doi":"10.3390/ddc2010012","title":"Optimizing Protein Production in Therapeutic Phages against a Bacterial Pathogen, Mycobacterium abscessus","year":2023,"lang":"en","type":"article","venue":"Drugs and Drug Candidates","topic":"Bacteriophages and microbial interactions","field":"Environmental Science","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Biology; Translation (biology); Gene; Genetics; Codon usage bias; Bacteriophage; Start codon; Stop codon; Phage therapy; Genome; Computational biology; Messenger RNA; Escherichia coli","score_opus":0.007070976741720812,"score_gpt":0.22562097371345033,"score_spread":0.21854999697172953,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4353060534","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970979,0.00007805106,0.000004604561,0.0007720703,0.00042775786,0.00035863774,0.000039735045,0.00009538505,0.0011258575],"genre_scores_gemma":[0.9970895,0.00013882793,0.00011434345,0.00008261692,0.00012840964,0.000075405536,0.000088843,0.000021701802,0.002260365],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99892604,0.000058220674,0.00021111987,0.00038447525,0.00009775752,0.00032236404],"domain_scores_gemma":[0.99966556,0.000019866597,0.0000725127,0.0001640334,0.000007134204,0.00007091559],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022203178,0.00016761108,0.00016009723,0.000087636756,0.00016271595,0.00012410691,0.000104643135,0.000048707876,0.0004198377],"category_scores_gemma":[0.000015640147,0.00014851535,0.000039012735,0.00033542485,0.000093818235,0.0003886534,0.00014396198,0.00012911124,0.00022841383],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000042686097,0.000038272086,0.00090981653,0.000017788407,0.000007913065,0.000011181506,0.002299968,0.00006236998,0.98457336,0.000007225324,0.00051185186,0.011517542],"study_design_scores_gemma":[0.0025700417,0.00015807748,0.16741087,0.00042303035,0.00007369355,0.000049688817,0.006668541,0.0013705312,0.6717492,0.00060405466,0.14724669,0.0016756176],"about_ca_topic_score_codex":0.000568675,"about_ca_topic_score_gemma":0.0004300888,"teacher_disagreement_score":0.31282422,"about_ca_system_score_codex":0.00009026438,"about_ca_system_score_gemma":0.000011885046,"threshold_uncertainty_score":0.605628},"labels":[],"label_agreement":null},{"id":"W4366772115","doi":"10.3390/ddc2020015","title":"Design, Synthesis and In Vitro Studies of 3-Amidocoumarins as Novel Antibiofilm Agents","year":2023,"lang":"en","type":"article","venue":"Drugs and Drug Candidates","topic":"Bacterial biofilms and quorum sensing","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Banaras Hindu University; Council for Scientific and Industrial Research, South Africa; Science and Engineering Research Board; Canadian Institute of Steel Construction","keywords":"Biofilm; Pseudomonas aeruginosa; Quorum sensing; Docking (animal); Chemistry; Microbiology; Antibiotics; In vitro; Context (archaeology); Antibiotic resistance; Bacteria; Biology; Biochemistry; Medicine","score_opus":0.01985490917465887,"score_gpt":0.2724799531335821,"score_spread":0.2526250439589232,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4366772115","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99852324,0.000862465,0.0000033971457,0.00020141569,0.00008127098,0.00012754214,0.000045268633,0.000010758272,0.00014467018],"genre_scores_gemma":[0.99659115,0.0026844463,0.00031222275,0.000081178565,0.000042146556,0.0000058571213,0.000044069115,0.00001436424,0.00022459448],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992215,0.000037360736,0.00018565623,0.00027748354,0.00006818227,0.00020981],"domain_scores_gemma":[0.99964935,0.000069135385,0.00006443207,0.00013108482,0.000034203887,0.000051794097],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025641415,0.00013951279,0.0002341256,0.00008574294,0.000065762666,0.000022868484,0.000053611664,0.00006860497,0.0000029029443],"category_scores_gemma":[0.000095362964,0.000120009376,0.000028663355,0.00012230236,0.00013350141,0.000006307854,0.00015855236,0.00003923617,0.0000026353807],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017856898,0.000021808559,0.0019146261,0.00005277712,0.00005554194,0.000003980524,0.00041444565,0.0000048531706,0.99437535,0.000011176749,0.000408719,0.0025581764],"study_design_scores_gemma":[0.00041423933,0.00004006781,0.0042332187,0.000050961095,0.000020553849,0.000006357974,0.0010103175,0.00012480789,0.9928121,0.000025677231,0.0011079478,0.00015375372],"about_ca_topic_score_codex":0.00019711448,"about_ca_topic_score_gemma":0.000037137437,"teacher_disagreement_score":0.0024044227,"about_ca_system_score_codex":0.0000054467446,"about_ca_system_score_gemma":0.000025789128,"threshold_uncertainty_score":0.48938403},"labels":[],"label_agreement":null},{"id":"W4383370009","doi":"10.3390/ddc2030028","title":"Drugs of the Kallikrein–Kinin System: An Overview","year":2023,"lang":"en","type":"article","venue":"Drugs and Drug Candidates","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Medical Research Council; Canadian Institutes of Health Research; Medical Research Council Canada","keywords":"Kinin; Kallikrein; Kininogen; Bradykinin; Proteases; Medicine; Prekallikrein; Pharmacology; Angioedema; Receptor; Immunology; Biology; Internal medicine; Biochemistry","score_opus":0.02060281302863263,"score_gpt":0.2828391711462861,"score_spread":0.26223635811765345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4383370009","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9867187,0.0077265142,0.0000015896069,0.0015428236,0.00031854538,0.00034233122,0.00005666296,0.0001754143,0.003117378],"genre_scores_gemma":[0.99461037,0.0007133845,0.00002670422,0.00033103264,0.00018802566,0.000017798011,0.000092218674,0.000030727493,0.00398973],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99864215,0.00007137908,0.00036266638,0.000296394,0.00034153476,0.00028590616],"domain_scores_gemma":[0.9990469,0.00012070742,0.00014655733,0.00043963752,0.00008022673,0.00016594974],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041578955,0.00019040352,0.00039906,0.00010968118,0.00018405131,0.000037065525,0.00014589881,0.00006859646,0.00006312531],"category_scores_gemma":[0.000031846434,0.00012591286,0.00013663749,0.0004894917,0.00013619344,0.00012203043,0.00010262071,0.00009896734,0.000036398105],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004991931,0.00043542244,0.7128561,0.0061232736,0.00062463625,0.00006764209,0.059390567,0.00007075895,0.0055936463,0.09287683,0.05907352,0.0623884],"study_design_scores_gemma":[0.007064195,0.00038635643,0.79107094,0.0040543326,0.0010487533,0.00013604647,0.030721335,0.012113101,0.037289113,0.002935664,0.11198561,0.001194559],"about_ca_topic_score_codex":0.0009199749,"about_ca_topic_score_gemma":0.0000763101,"teacher_disagreement_score":0.08994117,"about_ca_system_score_codex":0.000030073128,"about_ca_system_score_gemma":0.00010514038,"threshold_uncertainty_score":0.5134578},"labels":[],"label_agreement":null},{"id":"W4392100829","doi":"10.3390/ddc3010012","title":"Correction: Marceau, F. Drugs of the Kallikrein–Kinin System: An Overview. Drugs Drug Candidates 2023, 2, 538–553","year":2024,"lang":"en","type":"article","venue":"Drugs and Drug Candidates","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Drug; Pharmacology; Medicine; Internal medicine","score_opus":0.010799971586044134,"score_gpt":0.26704560447119874,"score_spread":0.2562456328851546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392100829","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91156393,0.0644295,0.000014083189,0.0037993037,0.0049908166,0.0010989989,0.00038257247,0.0004704161,0.013250395],"genre_scores_gemma":[0.96135986,0.0017898008,0.000054391377,0.0005005657,0.00087607314,0.000060501046,0.00035649198,0.00010489665,0.034897417],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99638736,0.00023505489,0.00094664167,0.00092793565,0.000829677,0.0006733106],"domain_scores_gemma":[0.9976982,0.00047626236,0.00028904752,0.00088362285,0.00021479501,0.00043809332],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009307766,0.0006100541,0.0009229822,0.0003293204,0.00048498795,0.0002815088,0.00036554397,0.00018750982,0.00045435058],"category_scores_gemma":[0.00006170803,0.00043437662,0.0003993757,0.0009408116,0.00039804087,0.00047945097,0.00023635782,0.00045999003,0.00009284685],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012608342,0.000830839,0.16768377,0.009017001,0.0017327288,0.00017717307,0.09498654,0.00011442082,0.0029784685,0.029450133,0.61839134,0.07337679],"study_design_scores_gemma":[0.009615767,0.0007525304,0.09199747,0.016840557,0.0039569675,0.000978206,0.0688863,0.07886487,0.06779619,0.0032386936,0.65332025,0.0037521715],"about_ca_topic_score_codex":0.007630965,"about_ca_topic_score_gemma":0.00077076955,"teacher_disagreement_score":0.078750454,"about_ca_system_score_codex":0.0001987318,"about_ca_system_score_gemma":0.00046631112,"threshold_uncertainty_score":0.9998108},"labels":[],"label_agreement":null},{"id":"W4415680647","doi":"10.3390/ddc4040047","title":"Discovery and Characterization of 7,8-Dihydropyrido[4,3-d]pyrimidines as SARS-CoV-2 Entry Inhibitors","year":2025,"lang":"en","type":"article","venue":"Drugs and Drug Candidates","topic":"Pharmacological Receptor Mechanisms and Effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Emergent BioSolutions (Canada)","funders":"University of Illinois at Urbana-Champaign; University of Illinois at Chicago; University of Minnesota","keywords":"In vivo; In vitro; Docking (animal); Drug discovery; Virtual screening; Potency; Plasma protein binding; Binding site","score_opus":0.004188718560957869,"score_gpt":0.25377275115762205,"score_spread":0.24958403259666417,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415680647","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974926,0.0010737606,0.00011772888,0.00023559328,0.00021297892,0.00015129217,0.000035786332,0.00000957364,0.0006706573],"genre_scores_gemma":[0.9966702,0.0019312337,0.000022411992,0.00055158755,0.000082421015,0.000014858511,0.00013266463,0.000008042463,0.0005865865],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993183,0.00003928609,0.0001565774,0.00025985128,0.00006462297,0.00016134187],"domain_scores_gemma":[0.9997459,0.000021507165,0.000068002104,0.0000966808,0.000029276687,0.000038622646],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011626048,0.00013658415,0.00016625294,0.00004831676,0.000068392445,0.00004259461,0.000061570274,0.00008187239,0.000004285522],"category_scores_gemma":[0.000037303496,0.000109570734,0.000039604933,0.00007632904,0.00008589862,0.0000150043425,0.00013812188,0.000049818256,0.0000011535012],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000112829744,0.000036510803,0.0014098664,0.00006875643,0.000033681226,8.892002e-7,0.000063707696,4.0250742e-7,0.99403447,0.0004364437,0.00089754025,0.0029048817],"study_design_scores_gemma":[0.0004523476,0.00008336155,0.0006653707,0.00004492997,0.000028335706,0.0000018276886,0.000050267467,0.00007932158,0.987451,0.00038745662,0.010635997,0.00011978816],"about_ca_topic_score_codex":0.000055501252,"about_ca_topic_score_gemma":0.000006606853,"teacher_disagreement_score":0.009738456,"about_ca_system_score_codex":0.0000056974136,"about_ca_system_score_gemma":0.000036810015,"threshold_uncertainty_score":0.4468165},"labels":[],"label_agreement":null}]}